OTCMKTS:VREOD Vireo Growth (VREOD) Stock Price, News & Analysis $9.95 0.00 (0.00%) As of 09/18/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and TrendsSEC Filings About Vireo Growth Stock (OTCMKTS:VREOD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Vireo Growth alerts:Sign Up Key Stats Today's Range$9.95▼$9.9550-Day Range$9.95▼$9.9552-Week Range$8.91▼$24.00VolumeN/AAverage Volume14,588 shsMarket Capitalization$450.88 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Vireo Growth Inc. is a cannabis company focused on the cultivation, processing, manufacturing, and retail distribution of cannabis products in regulated U.S. markets. The company serves both medical and adult-use consumers through a combination of company-operated facilities, retail dispensaries, and branded product offerings. Its products and services may include cannabis flower, pre-rolls, concentrates, edibles, vape products, and other cannabis-derived goods, depending on the regulations and operating structure of each market. Vireo Growth has historically operated through state-based cannabis businesses, including cultivation and manufacturing facilities as well as dispensary locations. The company was formerly known as Goodness Growth Holdings Inc. and previously operated under the Vireo Health name before adopting Vireo Growth. Its business is subject to state-level cannabis regulations, licensing requirements, and restrictions that vary across the geographies it serves.AI Generated. May Contain Errors. Read More Vireo Growth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreVREOD MarketRank™: Vireo Growth scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingVireo Growth has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageVireo Growth has received no research coverage in the past 90 days.Read more about Vireo Growth's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth200.00% Earnings GrowthEarnings for Vireo Growth are expected to grow by 200.00% in the coming year, from $0.30 to $0.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vireo Growth is -3.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vireo Growth is -3.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVireo Growth has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for VREOD. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVireo Growth does not currently pay a dividend.Dividend GrowthVireo Growth does not have a long track record of dividend growth. News and Social Media3.3 / 5News Sentiment1.21 News SentimentVireo Growth has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Vireo Growth this week, compared to 1 article on an average week. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Vireo Growth insiders have not sold or bought any company stock.Percentage Held by Insiders3.80% of the stock of Vireo Growth is held by insiders.Percentage Held by InstitutionsVireo Growth has minimal institutional ownership at this time.Read more about Vireo Growth's insider trading history. Receive VREOD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vireo Growth and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VREOD Stock News HeadlinesVireo Growth Issues Shares to Resolve Altmore ObligationsSeptember 17, 2026 | tipranks.comVireo Growth Inc. Announces Issuance of Shares in Connection with Altmore SettlementSeptember 17, 2026 | financialpost.comFReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.September 21 at 1:00 AM | Base Camp Trading (Ad)Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore SettlementSeptember 17, 2026 | globenewswire.comVireo Growth Announces Conference Attendance for September 2026September 2, 2026 | globenewswire.comVireo Growth Expands Nevada Presence With C21 AcquisitionAugust 26, 2026 | tipranks.comVireo Growth Closes Acquisition of C21 Investments, Expands Nevada Cannabis FootprintAugust 24, 2026 | tipranks.comVireo Growth Closes C21 Deal to Boost Nevada Cannabis FootprintAugust 24, 2026 | tipranks.comSee More Headlines VREOD Stock Analysis - Frequently Asked Questions How have VREOD shares performed this year? Vireo Growth's stock was trading at $18.3870 on January 1st, 2026. Since then, VREOD shares have decreased by 45.9% and is now trading at $9.95. When did Vireo Growth's stock split? Vireo Growth's stock reverse split on Friday, June 5th 2026.The 1-30 reverse split was announced on Friday, June 5th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 5th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Vireo Growth? Shares of VREOD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/21/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:VREOD Previous SymbolOTCMKTS:GDNSF CIK1771706 Webgoodnessgrowth.com Phone(612) 999-1606FaxN/AEmployees500Year FoundedN/AProfitability EPS (Trailing Twelve Months)($3.30) Trailing P/E RatioN/A Forward P/E Ratio33.17 P/E GrowthN/ANet Income-$68.11 million Net Margins-23.37% Pretax Margin-11.22% Return on Equity-19.76% Return on Assets-7.15% Debt Debt-to-Equity Ratio0.70 Current Ratio1.20 Quick Ratio0.84 Sales & Book Value Annual Sales$268.77 million Price / Sales1.68 Cash FlowN/A Price / Cash FlowN/A Book Value$8.73 per share Price / Book1.14Miscellaneous Outstanding Shares45,315,000Free Float43,593,000Market Cap$450.88 million OptionableNot Optionable Beta1.78 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:VREOD) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vireo Growth Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vireo Growth With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
